EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Small Extracellular Vesicle‐Transmitted LncRNA CATED Promotes Platinum‐Resistance in High‐Grade Serous Ovarian Cancer

Yi Liu iD, Hanyuan Liu iD, Chenchen Zhu iD, Yan Yang iD, Zhen Shen iD, Ge Shan iD, Liang Chen iD, Ying Zhou iD

Advanced Science · 2025-08 · 12 (31)

DOI: 10.1002/advs.202505963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.06.2025. Verfasst von Yi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Core Facility Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Univers…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Ovarian Neoplasms, Drug Resistance, Neoplasm, Extracellular Vesicles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, USTC Research Funds of the Double First-Class Initiative, 2020 USTC Affiliated Hospital Introduction Project to Medical Leading Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐grade serous ovarian cancer (HGSOC) is the most lethal type of gynecological cancer, and platinum‐resistance is a serious challenge in its treatment. Long non‐coding RNAs (lncRNAs) play critical regulatory roles in the occurrence and development of cancers. Here, using RNA sequencing of tumor small extracellular vesicles (sEVs) from HGSOC patients, the lncRNA CATED is identified as significantly upregulated in both tumors and tumor‐derived sEVs in platinum‐resistant HGSOC, and low CATED levels correlate with good prognosis. Functionally, CATED enhances cisplatin resistance by promoting cell proliferation and inhibiting apoptosis in vitro and in vivo. These effects could be transferred via CATED‐overexpressing sEVs from donor cells and HGSOC tumor sEVs. Mechanistically, CATED binds to and upregulates DHX36 via PIAS1‐mediated SUMOylation at the K105 site, and elevated DHX36 levels increase downstream RAP1A protein levels by enhancing RAP1A mRNA translation, consequently activating the MAPK pathway to promote platinum‐resistance in HGSOC. Antisense oligonucleotide mediated knockdown of CATED reverse platinum‐resistance in sEV‐transmitted mouse models via the DHX36‐RAP1A‐MAPK pathway. This study newly identifies a sEV‐transmitted lncRNA CATED in driving HGSOC platinum‐resistance and elucidates the mechanism it regulates the interacting protein through SUMOylation. These findings also provide a novel strategy for improving chemotherapy in HGSOC by targeting CATED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingOvarian NeoplasmsDrug Resistance, NeoplasmExtracellular VesiclesCystadenocarcinoma, SerousFemaleHumansMiceAnimalsCell Line, TumorCisplatinMice, NudeGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

DHX36lncRNAsovarian cancerplatinum resistancesmall extracellular vesicles

Substanzen

RNA, Long NoncodingCisplatin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Core Facility Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
  • Hefei National Laboratory for Physical Sciences at Microscale, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, The RNA Institute, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China,…
  • Department of Cardiology, The First Affiliated Hospital of USTC, The RNA Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.

ORCID-Profile: Yi Liu, Hanyuan Liu, Chenchen Zhu, Yan Yang, Zhen Shen, Ge Shan, Liang Chen, Ying Zhou

Förderung

  • National Natural Science Foundation of China
  • USTC Research Funds of the Double First-Class Initiative
  • 2020 USTC Affiliated Hospital Introduction Project to Medical Leading Technology
  • Anhui Universities Outstanding Youth Research Project
  • Research Funds of Center for Advanced Interdisciplinary Science and Biomedicine of IHM
  • Anhui Provincial Key Research and Development Plan

Zitieren

APA

Liu, Y., Liu, H., Zhu, C., Yang, Y., Shen, Z., Shan, G., Chen, L., & Zhou, Y. (2025). Tumor Small Extracellular Vesicle‐Transmitted LncRNA CATED Promotes Platinum‐Resistance in High‐Grade Serous Ovarian Cancer. Advanced Science, 12(31). https://doi.org/10.1002/advs.202505963

Vancouver

Liu Y, Liu H, Zhu C, Yang Y, Shen Z, Shan G, et al. Tumor Small Extracellular Vesicle‐Transmitted LncRNA CATED Promotes Platinum‐Resistance in High‐Grade Serous Ovarian Cancer. Advanced Science. 2025;12(31). doi:10.1002/advs.202505963

BibTeX
@article{Liu2025,
  author = {Liu, Yi and Liu, Hanyuan and Zhu, Chenchen and Yang, Yan and Shen, Zhen and Shan, Ge and Chen, Liang and Zhou, Ying},
  title = {Tumor Small Extracellular Vesicle‐Transmitted LncRNA CATED Promotes Platinum‐Resistance in High‐Grade Serous Ovarian Cancer},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {31},
  doi = {10.1002/advs.202505963}
}
Kostenlos starten →